Status:
RECRUITING
Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia
Lead Sponsor:
Guangzhou 8th People's Hospital
Conditions:
AIDS
Pneumonia
Eligibility:
All Genders
18-65 years
Brief Summary
Screening for risk factors related to lung function impairment in patients who have recovered from AIDS with severe pneumonia, to provide clinical evidence for early identification and intervention of...
Detailed Description
This is a prospective, single-center, non-randomized, clinical observational cohort study. It involves monitoring lung function at discharge (baseline, 0w), and at the 4th, 8th, 12th, 24th, and 48th w...
Eligibility Criteria
Inclusion
- Confirmed HIV infection;
- Progression to the AIDS stage: CD4+ count \<200 cells/µL and/or occurrence of opportunistic infections associated with AIDS;
- Age between 18 to 65 years;
- Meet the diagnostic criteria for severe pneumonia, with reference to the 2021 treatment guidelines for community-acquired pneumonia developed by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA).
Exclusion
- Concurrent central nervous system lesions, severe liver disease, or cirrhosis;
- Concurrent AIDS-related or non-related tumors;
- Women who are pregnant or breastfeeding;
- Presence of serious underlying diseases such as heart, lung, liver, kidney, etc.;
- Alcohol abuse or drug use;
- The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06137196
Start Date
November 1 2023
End Date
November 1 2027
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Guangzhou, Guangdong, China, 510060